Pioneering Methods in Brain Optimization and Mental Health Treatment.
ACS medicinal chemistry letters March 14, 2024 DOI: 10.1021/acsmedchemlett.4c00058 via PubMed
Summary
AI-generated from the abstractRecent innovations in neurostimulation, psychedelic therapy, and brain function optimization are advancing personalized brain therapy. Methods for altering brain states include AI-driven non-invasive neurostimulation. The therapeutic potential of N-isopropyl tryptamines and tryptamine derivatives is examined, alongside psilocybin and psilocin crystalline forms for mental health and central nervous system disorders. These diverse approaches are compared for their mechanistic insights and therapeutic implications, contributing to neuroscience and mental health.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Interventions | AI-driven non-invasive neurostimulation N-isopropyl tryptamines tryptamine derivatives psilocybin psilocin |
| Keywords | Psychedelics Neuroscience Artificial intelligence Brain stimulation Mental health |
| Key finding | AI-driven non-invasive neurostimulation and tryptamine derivatives show promise for personalized brain therapy and mental health treatment. |
Abstract
This Patent Highlight explores ground-breaking advancements in neurostimulation, psychedelic therapy, and brain function optimization from recent innovations. It examines methods for altering brain states through AI-driven non-invasive neurostimulation, potentially contributing to personalized brain therapy. The publication also delves into the therapeutic potential of N-isopropyl tryptamines and tryptamine derivatives. Furthermore, it discusses the therapeutic applications of psilocybin and psilocin crystalline forms in mental health and central nervous system disorders. By comparing and contrasting these diverse approaches, this work highlights their mechanistic insights, therapeutic implications, and contributions to the evolving fields of neuroscience and mental health.